Selected Balance Sheet Information

3 Months Ended

Mar. 31, 2023

Selected Balance Sheet Information

Selected Balance Sheet Information

6. Selected Balance Sheet Information

Prepaid expenses and other current assets (in thousands)

	March 31,		December 31,
	2023		2022
Prepaid clinical research organizations	$	2,474	$	2,293
Prepaid manufacturing expenses		879		418
Prepaid insurance		440		637
Receivable from prior owner		229		144
Prepaid consulting, subscriptions and other expenses		197		155
VAT receivable		4		87
Total	$	4,223	$	3,734

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services. Receivable from prior VCN owner includes amounts due related to research and development tax rebates, VAT and corporate taxes.

Property and equipment, net (in thousands)

	March 31,		December 31,
	2023		2022
Computers and office equipment	$	905	$	897
Other Property, Plant and Equipment		210		208
Leasehold improvements		94		94
Software		12		11
		1,221		1,210
Less: accumulated depreciation and amortization		(897)		(865)
Total	$	324	$	345

Accrued expenses (in thousands)

	March 31,		December 31,
	2023		2022
Accrued manufacturing costs	$	863	$	197
Accrued clinical consulting services		838		807
Accrued vendor payments		375		492
Total	$	2,076	$	1,496

Accrued employee benefits (in thousands)

	March 31,		December 31,
	2023		2022
Accrued bonus expense	$	325	$	1,216
Accrued vacation expense		142		100
Accrued compensation expense		182		87
Total	$	649	$	1,403